Babiuch, Amy S.
Conti, Thais F.
Conti, Felipe F.
Silva, Fabiana Q.
Rachitskaya, Aleksandra
Yuan, Alex
Singh, Rishi P. http://orcid.org/0000-0001-5859-8162
Clinical trials referenced in this document:
Documents that mention this clinical trial
Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis
https://doi.org/10.1186/s40942-019-0167-x
Funding for this research was provided by:
Regeneron Pharmaceuticals
Article History
Received: 14 December 2018
Accepted: 2 May 2019
First Online: 23 July 2019
Ethics approval and consent to participate
: Approved by Cleveland Clinic Investigational Review Board (IRB) and all patients signed an informed consent for their participation.
: Not applicable.
: TFC, FFC, and FQS have no competing interest to disclosure; ASB: received grants from Regeneron, personal fee from VINDICO and MCME Global; AR: received personal fee from Alcon, Allergan, and Zeiss; AY: received grants from Regeneron; RPS: received grants and personal fees from Regeneron, Genentech/Roche, Apellis, Optos, Zeiss, Biogen, and Alcon/Novartis outside the submitted work.